SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-243629
Filing Date
2018-08-09
Accepted
2018-08-09 09:16:51
Documents
66
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d585873d10q.htm 10-Q 831741
2 EX-31.1 d585873dex311.htm EX-31.1 8300
3 EX-31.2 d585873dex312.htm EX-31.2 8207
4 EX-32.1 d585873dex321.htm EX-32.1 6029
  Complete submission text file 0001193125-18-243629.txt   4267780

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT snna-20180630.xml EX-101.INS 555378
6 XBRL TAXONOMY EXTENSION SCHEMA snna-20180630.xsd EX-101.SCH 51298
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snna-20180630_cal.xml EX-101.CAL 55202
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snna-20180630_def.xml EX-101.DEF 234905
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE snna-20180630_lab.xml EX-101.LAB 468928
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snna-20180630_pre.xml EX-101.PRE 343249
Mailing Address 30699 RUSSELL RANCH ROAD, SUITE 140 WESTLAKE VILLAGE CA 91362
Business Address 30699 RUSSELL RANCH ROAD, SUITE 140 WESTLAKE VILLAGE CA 91362 (818) 629-2256
Sienna Biopharmaceuticals, Inc. (Filer) CIK: 0001656328 (see all company filings)

IRS No.: 273364627 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-38155 | Film No.: 181003687
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences